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Angiotensins I and II in renal vein blood. The concentrations of
active renin (PRC), angiotensin I (Al) and angiotensin II (All)
were measured by radioimmunoassay in blood drawn simultane-
ously and in triplicate from both renal veins and an artery in each
of 17 patients with hypertension, 10 of whom had evidence of
renal arterial or parenchymal disease. Plasma concentrations of
all three substances were found to be remarkably constant in
each of the three samples drawn within 5 mm from each site in
each patient. In the 6 patients who did not have unilateral renal
or renovascular disease, concentrations of renin and Al were (±
sEM), respectively, 11 3% and 25 (—14 to +144)% higher,
whereas All was 16 6% lower, in renal venous plasma than it
was in arterial plasma. In the 8 patients with predominantly uni-
lateral renin secretion, concentrations of Al and All were consis-
tently higher in venous plasma from the affected kidney than
they were from the unaffected kidney, whereas the respective
mean concentrations of renin, Al, and All were 4 4%, 7%
(—36 to +32)%, and 35 5% lower in venous plasma from the
unaffected kidney than they were in arterial plasma. The ratios of
the plasma concentrations of All to renin were lower in renal
venous than they were in arterial plasma. Plasma concentrations
of Al were closely and similarly related to PRC at all sites. There
were highly significant positive correlations between PRC and
Al, PRC and All, and Al and All, both in arterial and renal
venous plasma (r = 0.79 to 0.86. P <0.001). The present studies
thus confirm by direct measurement in vivo the ability of the
normal kidney to remove All from the circulation, and they em-
phasize the limited capacity for All formation within the renal
circulation.
Angiotensine I et II dans le sang de Ia veine rénale. Les concen-
trations de rénine active (PRC), d'angiotensine I (Al), et
d'angiotensine II (All) ont été measurées par radioimmunologie
dans le sang preleve simultanément et en triplicata des deux
veins rénales et d'une artère chez 17 malades atteints
d'hypertension artérielle, parmi lesquels 10 avaient des signes
datteinte rénale vasculaire ou parenchymateuse. La concentra-
tion plasmatique des trois substances est remarquablement con-
stante dans chacun des trois échantillons obtenus en 5 mm, d'un
même vaisseau, chez un méme malade. Chez les 6 malades qui
n'avaient pas de néphropathie ou d'anomalie vasculorénale les
concentrations de refine et de Al Ctaient (sEM) respectivement,
de 11 3% et 25 (—14 a +144)% supérieures alors que All était
inferieure de 16 6% dans le plasma veineux renal par com-
paraison au plasma artériel. Chez 8 malades dont Ia sécrétion de
rénine avait une predominance unilatérale les concentrations de
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Al et All étaient supérieures, dans le plasma veineux du rein
lésé, a celles du rein intact alors que les concentrations
moyennes de rénine, de Al et All Ctaient de 4 4%, 7 (—36 a
+32)% et 35 5%, respectivement, inférieures dans le plasma vei-
neux du rein intact par comparaison au plasma artériel. Le rap-
port de Ia concentration plasmatique de All 5. celle de refine
était inferieur dans le plasma veineux au méme rapport dans le
plasma artériet. Les concentrations plasmatiques de Al et de ré-
nine active Ctaient étroitement liees dans le méme sens, quelle que
soit l'origine de l'échantillon. 11 existe des correlations positives
trés significatives entre PRC et Al, PRC et All, et Al et All,
aussi bien dans le plasma veineux renal que dans le plasma arté-
riel (r = 0,79 a 0,86, P < 0.001). Les résultats obtenus con-
firment ainsi, par des mesures directes in vivo, Ia capacité du
rein normal a soustraire All de Ia circulation et mettent en ëvi-
dence le caractCre limité de Ia formation de All dans Ia circula-
tion renale.
Concurrent assessment of the plasma concentra-
tions of renin, angiotensin I (Al), and angiotensin II
(All) in renal venous and arterial blood are of con-
siderable potential interest for three principal rea-
sons. All, perhaps largely generated within the kid-
ney, may be an important determinant of renal
blood flow and function Ll-61; it is probable that the
kidney is a major site of All catabolism [7, 81; and in
the presence of unilateral renal disease, especially
renal artery stenosis, markedly different concentra-
tions of renin may be found in the two renal veins,
thus distorting the normal relationships between re-
nm, Al, and All on the two sides [9-111.
The aim of our study was to measure con-
currently the concentrations of active renin, Al,
and All in arterial and renal venous blood of man
and to compare net differences of these substances
across the kidneys in patients with and without evi-
dent unilateral renal disease.
Methods
Patients. Seventeen patients were studied, each
of whom had at least three out-patient recordings of
blood pressure in the supine position greater than
150/100 mm Hg. They gave informed consent to the
several procedures. All had renal arteriography
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with selective injections into each renal artery. The
following groups of patients were identified: (a) In
six patients, no kidney abnormality was defined; all
of these had normal concentrations of serum elec-
trolytes and normal renal clearance rates of creati-
nine; none had proteinuria. (h) in six, arteriography
revealed unilateral main renal artery stenosis or oc-
clusion; all of these had bilateral ureteric catheteri-
zation, which demonstrated either characteristic
features of renal ischemia [12, 131 or no urine flow.
Three further patients were distinguished in show-
ing consistently higher concentrations of renin in
renal vein blood in one side. One of these had a uni-
lateral hydronephrosis, one had a shrunken left kid-
ney, and one, albeit with a normal renal arteri-
ogram, had previously been in the malignant phase
of hypertension, and it was thought probable that
the resultant intrarenal vascular lesions had been
more severe on the left side [14]. One further pa-
tient had bilateral renal artery stenoses.
Sampling protocol. Thirteen patients had not
been taking any medication for at least 1 month.
Four others had severe hypertension and were
maintained on a short-acting sympatholytic drug,
bethanidine (Esbatal®, Burroughs-Wellcome),
which was discontinued 24 hours before sampling.
All patients ate the normal ward diet of normal so-
dium and potassium content.
After at least 1 hour of recumbency, the patients,
under local anesthesia, underwent the insertion of
catheters into a femoral artery with the Seldinger
technique. We inserted similarly additional cath-
eters into each femoral vein and placed their tips in
the renal veins, using fluoroscopic control. After
discarding dead-space blood, we withdrew samples
simultaneously from each site in sequence for mea-
surement of renin, Al, and All. In all, we obtained
three successive sets of samples within 5 mm.
We placed the blood for measurement of active
plasma renin concentration (PRC) into precooled
sequestrene tubes. For Al estimation, we placed
the blood in iced plastic bottles containing 100 ml of
aqueous ethanol (1:9, volume/volume) and shook
them vigorously [15]. For All estimation, we drew
blood into syringes containing 0.5 ml of an aqueous
solution of EDTA (disodium salt) and o-phe-
nanthroline, and we chilled it in ice to inhibit con-
verting enzyme and angiotensinases [161. We also
measured the packed cell volume (PCV). The blood
loss amounted to about 350 ml, which is not suf-
ficient to increase the peripheral plasma concentra-
tion of renin [17] or All [3]. Before we withdrew the
catheters, we performed venography to confirm
their location. The procedure had no adverse ef-
fects and the patients tolerated it well.
Laboratory methods: (1) Plasma renin concen-
tration. For this determination, we used a modifica-
tion [18] of the antibody-trapping method of Poul-
sen and Jorgensen [19], an excess of ox renin sub-
strate being added to the incubation mixture to give
zero order kinetics with respect to substrate and
hence a measure of renin concentration. Renin con-
centration was expressed as 1U/ml of the Inter-
national Standard Human Renin [20] by reference
to a standard curve. The within-batch coefficient of
variation was 7.1% (N = 20).
(2) Radioimmunoassay of Al!. We measured
plasma All immunoreactive material by the method
of Düsterdieck and McElwee [16]. We processed
samples from each subject immediately after their
collection. The recovery of All was 83 (sEM) 1.7%,
and a recent within-batch coefficient of variation
[21] was 8.6% (N = 16). The Al! antiserum had an
equal affinity for All, [des-Asp'i-AII, [des-
(Asp', Arg2)]-All, and [des-(Asp', Arg2, Val3)]-AIl
and a 0.6% cross reaction with Al [16, 22].
(3) Paper chromatography. We determined in
one patient (#14, Table 2) the contribution of immu-
noreactive metabolites of the hormone All to the
apparent Al! plasma concentration. We chromato-
graphed on paper half the Dowex extracts from
each plasma sample, as previously described in
detail [20, 21], and combined three samples from
each site. In brief, the solvent (butanol:acetic
acid:water:pyridine, 15:3:12:10) separated A!!,
[des-Asp']-All, and [des-(Asp', Arg2)]-AlI/[des-
(Asp', Arg2, Val3) i-All. We measured All and these
metabolites after elution from the paper with the
All antiserum mentioned before.
(4) Radioimmunoassay of Al. We measured A!
by a minor modification [21] of Waite's method [15].
We immediately processed samples from each pa-
tient and in the same batch. The Al antiserum had a
cross reaction of less than I x l0-% with All and
30% with des-Asp'-AI. The recovery of Al was 80
(sEM) 1.6%, and the within-batch coefficient of
variation was 10.1% (N = 9). The results, corrected
for recovery and PCV, are expressed as picomole
per liter of plasma. This assumes that there is no Al
in red blood cells.
Statistical methods. These included analysis of
variance and Student's t test. For paired results,
two-tailed paired t or Wilcoxon tests were used.
Correlations were calculated after log transforma-
tion of the data. Results are expressed as mean 1
SEM.
278 Semple et a!
Results
Variability of renin and angiotensin concentra-
tions in successive samples from each site. The
plasma concentrations of renin, Al, and All re-
mained very constant in successive samples drawn
from each site throughout the sampling procedure.
The coefficients of variation of each of the three sets
of samples from each site ranged from 9 to 17%.
Paper chromatography. The paper chromatogra-
phy experiments revealed that 70, 70, and 84% of
the All immunoreactive material in plasma from the
left renal vein, right renal vein, and artery, respec-
tively, chromatographed with the mobility of au-
thentic All (Fig. 1). Thus, little radioimmunoassay
interference occurred from immunoreactive metab-
olites of All.
Patients without unilateral renal disease. In the
six subjects without unilateral renal disease or later-
alizing renal vein renin levels (Table 1), the mean
concentration of active renin in renal venous
plasma was 11 3% higher than it was in arterial
plasma (paired t, P < 0.05). Concentrations of Al in
renal venous plasma were not significantly different
from those in arterial plasma (paired t, P> 0.2). By
contrast, the mean concentration of All in renal
venous plasma was 16 6% lower than it was in
arterial plasma (paired t, P < 0.02).
Patients with unilateral renal or reno vascular dis-
ease: (a) Comparison of the two renal veins. In
eight patients (#1 to #8, Table 2), renal venous PRC
was greater in one renal vein than it was in the other
in all three consecutive samples from each site in
each patient. Without exception, these patients also
showed consistent and similar differences between
the two renal veins for plasma concentrations of Al
and All; there were no subjects in whom a consis-
tent difference in plasma concentrations of one sub-
stance was not associated with a consistent dif-
ference in all three.
(b) Comparison of affected renal vein with artery.
In these patients with lateralizing features, the
mean concentrations of renin and AT also were
higher in venous plasma from the affected kidneys
compared to that in arterial plasma (paired Wil-
coxon test, P <0.01). In four of the subjects, con-
centrations of All were higher in renal venous than
they were in arterial plasma, and in four they were
lower. There was a significant correlation between
the changes in plasma levels of renin and All across
these kidneys (r = 0.91, P < 0.01).
I I I I I I
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All [des—Asp1] All [des—(Asp1, Arg2)] All!
[des—(Asp1, Arg2, Vs13)1 All
Fig. 1. Angiotensin II (Al!) immunoreactive material recovered from paper chromatograms of extracts of arterial blood (upper panel),
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Table 1. Renin, Al, and All in arterial and renal venous plasma from patients without unilateral renal disease
Artery Right renal vein Left renal veinRenal
Patient Age arteriography PRC PlasmaAI PlasmaAll PRC PlasmaAI PlasmaAll PRC PlasmaAl PlasmaAll
no. yr finding UI,nl pmole/liter pmolelliter pAl/mi pmoie/liter pmoielliter 1zUImi pmoielliter pmole/liter
1 18 Normal 32 10 23 39 10 15 38 9 18
2 50 Normal 52 4 12 60 4 14 56 5 14
3 40 Normal 37 9 20 35 22 14 39 19 12
4 35 Normal 44 — 16 44 — 15 46 — 14
5 32 Normal 15 7 15 16 7 15 15 6 13
6 18 Normal 102 13 33 117 12 20 139 13 19
Table 2. Renin, Al, and All in arterial and renal venous plasma from patients with renal or renovascular disease
Artery Affected renal vein Unaffected renal vein
Pa—
tient Age Renal arteriography PRC Plasma Al Plasma All PRC Plasma Al Plasma All PRC Plasma Al Plasma All
no. yr finding /.LU/ml pmolelliter prnolelliter pAl/mi pmole/liier pmolelliter p.U/ml pmole/liter pmole/liter
With evidence of unilateral renal secretion
7 57 R. renal artery occlusions 50 10 20 138" 58" 31" 49 8 14
8 50 L. renal artery occlusion 295 49 102 746" 195" 188" 276 52 46
9 46 R. renal artery occlusion 99 22 28 484" 99" 94b 101 15 17
10 47 R. renal artery stenosis 48 11 21 59" 20b 17' 47 10 12
11 56 L. renal artery stenosis 28 — 9 47') — I 1" 30 — 9
12 23 Small L. kidney 23 2 16 28" 10" 14" 17 2 10
13 36 L.hydronephrosis 95 18 20 III" 27b 15b 83 12 11
14 26 Normalc 108 39 43 146" 81" 36b 108 61 25
No evidence of unilateral r,'nin secretion
15 60 R.renalarterystenosis 31 6 15 30 7 16 30 5 16
16 38 SmallR.kidney 64 16 23 67 17 21 80 18 19
Affected renal vein Affected renal vein
17 62 Bilateralrenalartery 6 3 7 10 7 6 10 10 7
stenosis"
Bethanidine was given until 24 hours before sampling.
" Values exceeded those in the other renal vein in all three pairs of samples.
Patient had previous malignant phase hypertension.
(c) Comparison of unaffected contralateral renal
vein with artery. In contrast to the patients without
unilateral renal disease, the mean concentration of
renin in renal venous plasma from the contralateral
kidneys was slightly (4 4%) but not significantly
lower than it was in arterial plasma. Levels of Al in
renal venous plasma from the contralateral kidneys
were not significantly different from levels in arteri-
al plasma (mean change, —7%; range, —32% to
+36%). Plasma concentrations of All across these
kidneys showed a greater percentage fall (35 5)
than did concentrations across those kidneys of the
group with lateralizing features (t, P < 0.05).
Correlations between PRC, plasma Al, and All
(all patients). There were positive correlations in
arterial plasma between the concentrations of renin
and AT (r = 0.82), renin and All (r = 0.86), and AT
and All (r = 0.84). Similar correlations were seen in
renal venous plasma between renin and AT (r =
0.79), renin and All (r = 0.88), and Al and All (r =
0.84). All the correlations were highly significant (P
< 0.001). Figure 2 shows these relationships. It is
apparent that the relationship between the plasma
concentrations of Al and renin was similar in arteri-
al and renal venous blood. Plasma concentrations of
All were, however, generally lower in relation to
renin in renal venous than they were in arterial
blood. An analysis ol variance showed that the in-
tercepts of the lines relating the plasma concentra-
tions of renin and All in both arterial and renal
venous blood were not significantly different from
zero. In comparison with arterial plasma, the ratios
of the concentrations of All to renin were lower in
venous plasma from the kidneys of patients without
unilateral renal disease (paired t =
—3.6, P <0.01),
both from diseased (paired t =
—8.1,P <0.001) and
contralateral kidneys (paired t = 4.1, P <0.01).
Discussion
Considerable variations in peripheral plasma re-
nm activity have been reported in recumbent sub-
jects sampled at intervals of 20 mm [23]. Judging
1.5 2.5 3.0
Log10 plasma AI,pmole/Iiter Log10 plasma All, pmo/e///ter Log10 plasma All,pmolc//iter
Fig. 2. Relations/sip hetneen PRC andplasma Al (left panel). PRC and plasma All (middle panel), andplasma Al and All (right panel).
Closed circles (.) represent values in arterial blood. Open circles (0) represent values in renal venous blood. Regression lines have been
drawn by the method of least squares for arterial blood I ) and for renal vein blood (——-——1.
from the low coefficients of variation of our mea-
surements in the present work, renin and angioten-
sin levels remained remarkably constant throughout
the period of sampling, which was usually about 5
mm. This is important since many centers use a se-
quential sampling technique, taking blood in turn
from one renal vein after the other with one cath-
eter. Differences in concentrations of renin and an-
giotensin in renal venous and arterial blood may be
small and difficult to detect [141, however, and such
changes can be more readily appreciated when mul-
tiple samples are drawn simultaneously from both
renal veins.
In a previous study, the conversion of endoge-
nous Al by the human lung was quantified from
measurements of levels of Al and All in blood
drawn simultaneously from the pulmonary artery
and left ventricle [21]. This was possible because
the vascular bed of the lung has no angiotensinase
activity [24]. By contrast, the kidney, in common
with most organs, destroys All; studies on the fate
of large amounts of All (0.5 to I gImin) infused
into the renal artery of the dog have demonstrated
that 75% is lost in one circulation [25]. The present
work was limited, therefore, to a consideration of
the net effect of the kidney on circulating angioten-
sins. The mechanism of these changes has not been
elucidated.
Most authors have concluded that blood and the
renal vasculature have a limited capacity for the
conversion of Al to All. Vane has reviewed the evi-
dence in detail [24]. Renal epithelial tissues, notably
glomeruli and the brush border of the proximal tu-
bule, are rich in converting enzyme [26, 27]. Immu-
noreactive All is present in high concentration in
the rat kidney [6] and in renal lymph from the dog
[7]. We found that the net extraction of All was
greater across kidneys that did not show net secre-
tion of renin than it was across kidneys that were
secreting renin. Across four kidneys with narrowing
of the main renal artery and large positive venoarte-
rial differences in plasma renin concentration, the
venoarterial differences in plasma levels of All was
positive. It seemed likely, therefore, that a propor-
tion of the All in renal vein plasma from kidneys
that were secreting renin was formed within the kid-
ney and that this proportion was determined by the
venoarterial difference in plasma concentration of
renin. It remains uncertain whether this All is
formed mainly in the vascular bed or the interstitial
tissue. Thus, renal vasculature has limited capacity
to form All. By contrast, the ratio of active renin to
Al was similar in arterial and renal venous plasma.
Leary and Ledingham [30] have reported that in
rats with one clipped renal artery, the contralateral
kidney had a reduced capacity to destroy All com-
pared with either clipped kidneys or kidneys from
normal animals. They speculated that this reduced
renal extraction could contribute to raised peripher-
al blood levels of All in this model. Our observa-
tions of net extraction of All by the unaffected kid-
ney in hypertensive man with unilateral renal artery
stenosis do not support their hypothesis. Bailie and
Oparil [8] have reported increased rates of metabo-
lism of isotopically labeled All in response to re-
ductions of renal blood flow in the canine kidney. In
patients with renal artery stenosis, increased All
formation in the affected kidney may conceal this
effect. In the present work, there was no definite
evidence of net extraction of active renin by the
contralateral kidney, as was noted for total renin in
some dogs with renal artery constrictions [29]. Re-
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nm secretion was, however, clearly suppressed on
that side.
We have confirmed that arterial plasma All levels
are in a range capable of affecting renal blood flow
[I]. [Des-Aspi-All (or "angiotensin III") is equipo-
tent with All in reducing renal blood flow and renin
secretion in the dog [30], and that this peptide medi-
ates the renal response of the renin-angiotensin sys-
tem has been suggested [311. In the one patient
studied, we found low concentrations of [des-Asp']-
All compared to All in renal venous and arterial
blood. Peripheral and mixed venous blood samples
from human subjects similarly contain low concen-
trations of immunoreactive metabolites or All f21,
221. Previous chromatography studies have failed to
demonstrate [des-Aspi-A!! as a metabolite of intra-
renal metabolism of '4C- or '251-AI1 in the dog [8,
321.
A further suggestion concerning the regulation of
renal blood flow is that Al rather than All could be
the effector hormone. In a study of isolated canine
kidneys, Al reduced renal blood flow, especially to
the inner cortex, and this reduction could not be
prevented by treatment with the nonapeptide inhib-
itor of converting enzyme [33]. High concentra-
tions of immunoreactive Al but not All have been
reported in renal vein blood from man and dog. We
have found much lower circulating levels of both
peptides.
The present studies show that the human kidney
vasculature has a distinctly limited capacity for the
formation of All in vivo, while serving as a prob-
ably important site of All catabolism.
Acknowledgments
Dr. J. K. Davidson and the Department of Radi-
ology at the Western Infirmary performed the cath-
eterizations, Ms. J. Miller gave technical assistance,
and Dr. M. Titterington gave advice on statistics.
Reprint requests to Dr. P. F. Seinpie, Medical Research
Council Blood Pressure Unit, Western infirmary, Glasgow Gil
OiVT, Scotland
References
HOLLENBERG NK, WILLIAMS OH, TAUB KJ, ISI-IIKAWA I,
BROWN C, ADAMS DF: Renal vascular response to inter-
ruptIon of the renin-angiotensin system in normal man. Kid-
,,ev Jut 12:285—293, 1977
2. HOLLENBERG NK, SOLOMON HS, ADAMS DF. ABRAMS HL.
MERRILL iF: Renal vascular responses to angiotensin and
norepinephrine in normal man. Circ Res 31:750—757, 1972
3. MORION ii, SEMELE PF, WAITE MA, BROWN ii, LEVER
AF, ROBERTSON JIS: Estimation of angiotensin I and 11 in
the human circulation by radioimmunoassay, in Hormones
in Human Blood, edited by ANTONIADES HN, Cambridge,
Mass., Harvard University Press, 1977, p. 620
4. TFIURAV K: Renal haemodynamics. Am i Med 36:698-717,
1964
5. THURAU K, SCHNERrIAN J, NAGEL W, HORSTER M, WAHL
M: Comparison of tubular fluid in the macula densa segment
as a factor regulating the function of the juxtaglomerular ap-
paratus. Circ Res (suppl 2) 21:11-79—11-89, 1967
6. MEN DELSOUN FAD: A method for measurement of anglo-
tensin 11 in tissues and its application to rat kidney. Clin Sci
Mol Med 51:111—125, 1976
7. BAILIE MD, RECTOR RC, SELDIN DW: Angiotensin II in ar-
terial and renal venous plasma and renal lymph in the dog. J
Clin invest 50:119—126, 1971
8. BAILIE MD, OPARIL 5: Relation of renal haemodynamics to
metabolism of angiotensin 11 by the canine kidney. Circ Res
41:283—287, 1977
9. GOCKE Di. GERTEN J, SHERwooo LM, LARAGH JH Physi-
ological and pathological variations of plasma angiotensin 11
in man. Circ Res (suppl 1) 24:1-131-1-146, 1969
10. BROWN ii, GAVRAS H, LECKIE B, LEVER AF, MACADAM R,
MORTON ii, ROBERTSON JIS: Acute circulatory renal fail-
ure: A probable manifestation of excess renin release, in
Control of Renin Secretion, edited by ASSAYKEEN TA, Ple-
num Press, New York, 1972, p. 277
II. SWALES JD, THURSTON 1-1: Plasma renin and angiotensin II
measurement in hypertensive and normal subjects: Correla-
tion of basal and stimulated states. I Clin Endocrinol Metab
45:159—163, 1977
12. STAMEY TA: Some observations on the filtration fraction
and the transport of sodium and water in the ischaemic kid-
ney and on the prognostic importance of RPF to the con-
tralateral kidney in renovascular hypertension, in Anti-
hypertensive therapy, edited by GROSS F, Berlin, Springer-
Verlag, 1966, p. 555
13. BROWN ii, OWEN K, PEART WS, ROBERTSON JIS, SUTTON
D: The diagnosis and treatment of renal-artery stenosis. Br
Mcdi 2:327—338, 1960
14. MAXWELL MH. MARKS LS, VARADY PD, Lvu AN. KAUF-
MAN JF: Renal vein renin in essential hypertension. J Lab
Cliii Med 86:901—909, 1975
15. WAITE MA: Measurement of concentration of angiotensin I
in human blood by radioimmunoassay. Clin Sci Mol Med
45:51—64, 1973
16. DUSFERDIECK G, MCELWEE G: Estimation of angiotensin II
concentration in human plasma by radioimmunoassay:
Some applications to physiological and clinical states. Fur I
Clin invest 2:32—38, 1971
17. BROWN ii, DAVIES DL. LEVER AF, R0BERr5ON JIS, VER-
NIORY A: The effect of acute hemorrhage in the dog and man
on plasma-renin concentration. J Phvsiol 182:649-663, 1966
18. MILLAR JA, LECKIF, Bi, SEMPLE PF, MORTON ii, S0NKODI
5, ROBERTSON JIS: Active and inactive renin in human
plasma: Renal arterio-venous differences and relationships
with angiotensin and renin substrate after various stimuli.
Circ Res (suppl 2) 43:1-120—1-127, 1978
19. POULSEN K, JORGENSEN J: An easy radioimmunological mi-
croassay of renin activity, concentration and substrate in hu-
man and animal plasma and tissues based on angiotensin I
trapping by antibody. J Clin Endocrinol Metab 39:816—825,
1974
20. BANGHAM DR, ROBERTSON 1, ROBERTSON ilS, ROBINSON
Ci, TREE M: An international collaborative study of renin
282 Seinpie et al
assay: Establishment of the international reference prepara-
tion of human renin. C/in Sci Mol Med 48:135s—159s, 1975
21. SEMPLE PF: The concentration of angiotensins I and II in
blood from the pulmonary artery and left ventricle of man. J
C/in Endocrino/ Metab 44:915—920, 1977
22. SEMPLE PF, Bovo AS, DAWES PM, MORTON ii: Angioten-
sin II and its heptapeptide (2—8), hexapeptide (3—8) and pen-
tapeptide (4-8) metabolites in arterial and venous blood of
man. Circ Res 39:671—678, 1976
23. WEINHERGER MH, ROSNER DR. KEM DC. JOYNER L,
FOUST U: Early morning variation in plasma renin activity in
normal recumbent humans, in Contro/ of Renin Secretion,
edited by ASSAYKEEN TA, New York, Plenum Press, 1972,
p. 189
24. VANE JR: The fate of angiotensin 1, inAngiotensin edited by
IAGE IM AND BUMPUS FM, Berlin, Springer-Verlag, 1974,
p. 31
25. HODGE RL, NG KKF, VANE JR: Disappearance of angioten-
sin from the circulation of the dog. Nature 215:138—141, 1967
26. CALDWELL PRB. SEEGAL BC, Hsu KC, DAS M, SOFFER
RL: Angiotensin-converting enzyme: Vascular endothelial
localization. Science 191:1050—1051, 1976
27. WARD PE, GEDNEY CU, DOWBEN RM, ERDOS EU: Isola-
tion of membrane-bound renal kallikrein and kininase. Bio-
chern J 15 1:755—758, 1975
28. LEARY WP, LEDINGHAM JG: Renal and hepatic inactivation
of angiotensin in rats: Influence of sodium balance and renal
artery compression. C/in Sc/ 38:157-174, 1970
29. HOSIE KF, BROWN JJ, HARPER AM, LEVER AF, MACADAM
RF, MACGREGOR J, ROBERTSON JIS: The release of renin
into the renal circulation of the anaesthetized dog. C/in Sci
38:157—174, 1970
30. FREEMAN RH, DAVIS JO, LOHMEIERTE: Des-l-Asp-Angio-
tensin 11: Possible intrarenal role in homeostasis in the dog.
Circ Res 37:30—34, 1975
31. DAVIS JO, FREEMAN RH: The other angiotensins. Biochem
Phartnaco/ 26:93—97, 1977
32. OPARIL S, BAILIE MD: Mechanisms of renal handling of an-
giotensin II in the dog. Circ Res 33:500—507, 1973
33. ITSKOVITZ HD, MCGIFF, JC: Hormonal regulation of the
renal circulation. Circ Res 34 (suppl fl:1-65—1-73, 1974
